Difficulty: Medium
Average Score: 72%
Practice
A client is starting therapy with docetaxel. Which of the following findings should the nurse instruct the client to report?
Correct answer
B
Rationale
In the context of pharmacology and specifically with docetaxel therapy, it is crucial for the nurse to instruct the client to report dyspnea. Docetaxel is a chemotherapy medication known to cause pulmonary toxicity, including interstitial pneumonia and acute respiratory distress syndrome. Dyspnea can be an early sign of these serious respiratory adverse effects and prompt reporting can lead to timely intervention to prevent further complications.
Regarding the other options:
A) Flushing is not typically associated with docetaxel therapy, so it is not a priority finding to report.
C) Hyperglycemia is a potential side effect of some medications but is not a common or significant adverse effect of docetaxel.
D) Tinnitus is not a common side effect of docetaxel and is not a priority finding in this context.
Educationally, this question highlights the importance of understanding common side effects and potential adverse reactions of medications, as well as the significance of prioritizing specific findings that could indicate serious complications. Nurses need to be vigilant in educating clients about potential side effects and the importance of timely reporting to ensure safe and effective pharmacological therapy.
Regarding the other options:
A) Flushing is not typically associated with docetaxel therapy, so it is not a priority finding to report.
C) Hyperglycemia is a potential side effect of some medications but is not a common or significant adverse effect of docetaxel.
D) Tinnitus is not a common side effect of docetaxel and is not a priority finding in this context.
Educationally, this question highlights the importance of understanding common side effects and potential adverse reactions of medications, as well as the significance of prioritizing specific findings that could indicate serious complications. Nurses need to be vigilant in educating clients about potential side effects and the importance of timely reporting to ensure safe and effective pharmacological therapy.